Home

INCYTE CORP

CIK 879169 · last filed 2021-01-25

INCYTE CORP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider was granted $8.7M of MRUS on Jan 25, 2021. Across all open-market trades the lifetime net is +$57.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.1M across reported positions. The firm reports its address in Wilmington, DE. 250 SEC filings were submitted jointly with JULIAN BAKER.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.05M

Companies

2

Total Filings

4

Lifetime Open-Market Net

$57.12M

Filer Profile

Reported Address
1801 AUGUSTINE CUT-OFF
WILMINGTON, DE 19803
Phone
(302) 498-6700
State of Incorporation
DE
Formerly Known As
INCYTE INC (2003–2003)
INCYTE GENOMICS INC (2000–2003)
INCYTE PHARMACEUTICALS INC (1994–2000)
Related Filers
JULIAN BAKER — 250 joint filings, latest 2026-07-02
FELIX BAKER — 170 joint filings, latest 2026-07-02
BAKER BROS. ADVISORS LP — 96 joint filings, latest 2026-07-02
PAULA J SWAIN — 90 joint filings, latest 2025-07-16
667, L.P. — 82 joint filings, latest 2026-07-02
Baker Brothers Life Sciences LP — 82 joint filings, latest 2026-07-02
Baker Bros. Advisors (GP) LLC — 81 joint filings, latest 2026-07-02
Barry P Flannelly — 77 joint filings, latest 2025-10-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Merus N.V. (MRUS) Delisted 10%+ Owner 3,550,000 $90.00 $319.50M $0 1 2021-01-25
AGEN 10%+ Owner 855,744 $8.24 $7.05M $57.12M 3 2020-06-18

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-01-25 Merus N.V. (MRUS) Delisted Grant (A) +350,000 $8.66M EDGAR
2020-06-18 AGEN Sell (S) −214,000 -$782.8K EDGAR
2020-06-15 AGEN Sell (S) −577,000 -$2.10M EDGAR
2017-02-14 AGEN Buy (P) +10,000,000 $60.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.